Precision Access
for Precision Medicine
a multi-omic data platform to transform GI care from plate to bedside
The SIMBA GI PLATFORM delivers multi-omic datasets from the whole GI tract, including the intensely bioactive small intestine.
Monitoring treatment induced changes
Validating product induced microbiome changes
Advancing fecal transplant-induced treatments
Correlating multi-omic
profiles with disease states
Monitoring progression or regression of disease
Measuring environmental and genetic influences on microbiome composition
The SIMBA GI Platform leverages the SIMBA suite of capsule to autonomously transit the GI tract to COLLECT, SEAL and PRESERVE a multi-omic fluid biopsy from the deepest regions of the small intestine.
The small intestine has a large impact on our health throughout our day-to-day lives, with it’s critical role in both the digestion and absorption of nutrients, it’s connection with our brain, and the presence of microbiota that work to maintain our immune system. The better we understand the composition of our small intestine, the better we can develop therapeutic approaches to transform the approach to healthcare and improve the lives for all.
​
Our current understanding of the gut microbiome is based on the microbiota found within stool samples, which insufficiently characterizes the microbial characterization of the small intestine. Over 2000 differences have been found among bacterial communities found in stool collection compared to collections focused on the small intestine.
